Meridian Bioscience Inc. (United States) is listed on the Nasdaq and has a market capitalization of $46.54 million, with shareholders equity totaling $20.10 million.
The company employs approximately 560 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, Meridian Bioscience Inc. reported $80.00 Thousand in revenue, generating net income of $-59.50 million.
Key financial metrics include a P/E ratio of -0.78, a price-to-book (P/B) ratio of 2.32, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VIVO.